 Treatment tuberculosis incidence tuberculosis United lung common site infection extrapulmonary disease prevalent patients human immunodeficiency virus HIV Clinically active tuberculosis combination drugs therapy six-month regimen isoniazid rifampin pyrazinamide first months regimens patients HIV Monthly monitoring adverse effects treatment response necessary Compliance important factor successful treatment Treatment failure use toxic second-line drugs cases drug susceptibility studies useful